Digital Science
VC Fund
London, United Kingdom
Digital Science is a technology company serving the needs of scientific research, they provide software that makes the research process simpler and more efficient so that everyone can work smart and discover more.
- Total investments:
- 24
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries Digital Science invests in
SoftwareInformation TechnologyBiotechnologyPublishingLife Science
Stages Digital Science invests in
Funding RoundGrantSeed
Countries Digital Science invests in
United StatesUnited KingdomGermanyThe Netherlands
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Software 12 (50%)
- Information Technology 6 (25%)
- Biotechnology 4 (17%)
- Publishing 3 (13%)
- Life Science 3 (13%)
Stage
- Funding Round 10 (42%)
- Grant 9 (38%)
- Seed 5 (21%)
Country
- United States 12 (50%)
- United Kingdom 7 (29%)
- Germany 2 (8%)
- The Netherlands 1 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Betsy Donohue
V.P. of Publisher Business Development
|
V.P. of Publisher Business Development | Total investments: 0 | Find email | |
Daniel Hook
CEO
|
CEO | Total investments: 0 | Find email | |
Greg Timbol
VP Corporate Sales
|
VP Corporate Sales | Total investments: 0 | Find email | |
|
John Treadway
Director
|
Director | Total investments: 0 | Find email | |
|
Lisa Hulme
Head of PR
|
Head of PR | Total investments: 0 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Syntheos
|
Pathfinder is an applied intelligence platform that focuses on practical issues ranging from materials engineering to clinical practice. | $33.5K / Grant / Dec 19, 2025 | |
FigureTwo
|
FigureTwo is a platform where scientific figures are created, which are engaging and accessible for researchers and institutions. | $33.5K / Grant / Dec 19, 2025 | |
OntoChem
|
OntoChem is an IT company that provides services such as customizable text analysis and data mining products. | Seed / Sep 29, 2021 | |
Intoolab
|
Intoolab is an Artificial Intelligence company, focused on Bayesian Inference, with the main product being Tzager the "Tensorflow" of Bayesian Networks. Tzager is the first Bayesian Inference A.I. framework in python, built for biomedical research, drug discovery, and personalized medicine with the main features being BiochemicalAnalysis, Predictor Research/Models, and Literature Intelligence. Tzager is not just another deep learning algorithm trained to solve very specific problems, but an intelligence system with its own framework based on Causal Equations and Bayesian Networks. Tzager has created its understanding of how the human body works by emulating how we humans understand Biomedicine through causal reasoning and experience, powered by its Healthcare Bayesian Network. | Grant / Sep 25, 2019 | |
CC Technology
|
CC Technology has unrivalled expertise in the domain of online application processing and grant management systems with over 10 years experience of delivering and supporting for prominent grant making bodies across the globe. | Seed / Jan 22, 2019 | |
Anywhere Access
|
Anywhere Access is a next-generation library solution that delivers one-click access to the full-text PDF for both Open Access and library-subscribed content. Designed to keep pace with the needs of today's researchers, Anywhere Access' cloud-based system connects researchers on and off campus, and is integrated with popular librarydiscovery tools, scholarly search engines, publisher platforms and scholarly networking sites. For unsubscribed content, Anywhere Access offers optional integrated document delivery services for over 5000 journals. | Seed / Jul 25, 2018 | |
Ripeta
|
Ripeta is a software and services company assessing scientific reproducibility. | $30K / Grant / Sep 18, 2017 | |
IFI CLAIMS
|
IFI CLAIMS produces U.S.-based patent databases for patent researchers.The company offers chemical, utility, design and plant, and business method patents. It also provides indexing and database creation, database management, patent portfolio, patent intelligence and technology report, IPC and U.S. patent concordance, assignee thesaurus,patent books and journals, and custom search services.IFI CLAIMS provides global patent information through CLAIMS Direct web services. It helps developers, analysts, and information professionals create scalable applications and analytics solutions that include patent data.The company produced its first in-depth U.S. chemical patent index, Uniterm Index in 1955, averaging 20 to 25 keyword terms per U.S. patent. Uniterm Index was initially offered in a printed, dual dictionary format. In 1967, it began delivering Uniterm Index in an electronic form complete with proprietary search software for use within corporate information departments.During the late 1970’s, IFI CLAIMS’ U.S. patent databases entered the world of interactive online searching when they became the first patent databases offered by Lockheed’s Dialog Information Services. It continued to expand the depth and breadth of their U.S. patent content to include all patented technologies, patent citations, legal status changes, reassignments, and published applications.IFI CLAIMS was founded in 1955 and is headquartered in Madison, Connecticut. | Jan 24, 2017 | |
Peerwith
|
Peerwith is a peer-2-peer marketplace connecting academics with experts in researcher services. We foster collaboration giving researchers the opportunity to improve the quality of their academic work while building lasting relationships with peers from their academic discipline. | Jan 17, 2017 | |
Strateos
|
Strateos automates chemistry, biology, and tissue analysis into closed-loop robotic labs that accelerate drug discovery programs. Through a combination of best-in-class robotics and control systems, advanced software for imaging and analytics, and remote cloud laboratories, they enable pharmaceutical partners to more rapidly and efficientlydiscover new drug candidates.Born of a merger between Transcriptic and 3Scan, Strateos combines the strengths of those companies to amplify their impact and accelerate drug discovery. Transcriptic developed the first robotic cloud laboratory platform for on-demand life science research, which is currently in use at several top pharmaceutical and biotechnology companies. 3Scan combined automation, machine learning and computer vision to extract spatial data from tissue samples and create detailed 3D representations as well as quantitative analysis of complex anatomical structures. Now these two portfolios will be combined to offer a suite of technologies for accelerating drug discovery and early development.By expressing life science methods as data, infrastructure virtualization will become possible. "Science-as-a-Service" will power the next generation of discovery, driven by huge efficiencies of both time and money.Transcriptic was founded in 2012 to create a better way to get lab work done. Tired of spending endless hours at the bench pretending to be slow, error-prone robots, they set out to build a modern solution to the day-to-day process of wet lab biology.Drawing on deep computer science and electrical engineering backgrounds in addition to life science, Strateos was born: a meticulously optimized, technology-enabled remote lab. Using state-of-the-art automation and control technology, and an emphasis on user experience and usability, they are working on building a stark contrast to the long, complicated sales process, high prices, and slow turnarounds of traditional CROs.They are working hard to build a great company that can be a true partner for your lab for a long time, progressively enabling ever greater levels of productivity and efficiency. They are scientists building for scientists. | $13.4M / Nov 17, 2016 | |
| See all 24 investments → | |||
Co-Investors
Holtzbrinck Digital
7 deals together
Bethnal Green Ventures
1 deal together
Big Red Ventures
1 deal together
DCVC
1 deal together
WuXi AppTec
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
SaaS Investors
99,274 investors
Enterprise Investors
77,348 investors
Software Investors
50,021 investors
Media (entertainment) Investors
29,128 investors
Biotech Investors
21,775 investors
Biotechnology Investors
19,370 investors
Life Science Investors
6,823 investors
Publishing Investors
3,732 investors
SaaS VC Funds
61,208 investors
FAQ
What does Digital Science invest in?
Digital Science invests primarily in Software, Information Technology and Biotechnology startups, most often at Funding Round and Grant stage. Most of the 24 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Digital Science?
Public channels for Digital Science include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Digital Science?
The team at Digital Science includes Betsy Donohue (V.P. of Publisher Business Development), Daniel Hook (CEO) and Greg Timbol (VP Corporate Sales), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
